MX2016006221A - Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños. - Google Patents

Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños.

Info

Publication number
MX2016006221A
MX2016006221A MX2016006221A MX2016006221A MX2016006221A MX 2016006221 A MX2016006221 A MX 2016006221A MX 2016006221 A MX2016006221 A MX 2016006221A MX 2016006221 A MX2016006221 A MX 2016006221A MX 2016006221 A MX2016006221 A MX 2016006221A
Authority
MX
Mexico
Prior art keywords
infants
oligosaccharide
young children
prevention
compositions
Prior art date
Application number
MX2016006221A
Other languages
English (en)
Inventor
Torp Sangild Per
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2016006221A publication Critical patent/MX2016006221A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/151—Johnsonii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/245—Salivarius
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Pediatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invención describe una composición que comprende una mezcla de oligosacáridos, dicha mezcla de oligosacáridos comprende de 40 a 80 % en peso de oligosacárido(s) fucosilado(s), de 10 a 50 % en peso de oligosacáridos N-acetilados, de 5 a 40 % en peso de oligosacárido(s) sialilado(s) y de 0 a 20 % en peso de precursor(es) de oligosacáridos de la leche humana, para usar en la prevención y/o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños.
MX2016006221A 2013-11-15 2014-11-14 Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños. MX2016006221A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13193057 2013-11-15
PCT/EP2014/074580 WO2015071402A1 (en) 2013-11-15 2014-11-14 Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children

Publications (1)

Publication Number Publication Date
MX2016006221A true MX2016006221A (es) 2016-08-08

Family

ID=49582654

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016006221A MX2016006221A (es) 2013-11-15 2014-11-14 Composiciones para usar en la prevencion o tratamiento de la enterocolitis necrotizante en infantes y niños pequeños.

Country Status (11)

Country Link
US (1) US11135232B2 (es)
EP (1) EP3071208B1 (es)
CN (2) CN105744938A (es)
AU (1) AU2014350157A1 (es)
ES (1) ES2895380T3 (es)
MX (1) MX2016006221A (es)
PH (1) PH12016500762A1 (es)
PT (1) PT3071208T (es)
RU (1) RU2016123460A (es)
WO (1) WO2015071402A1 (es)
ZA (1) ZA201604034B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1231398A1 (zh) * 2014-04-08 2017-12-22 Abbott Laboratories 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
CN107106584A (zh) * 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
MX378680B (es) * 2015-03-05 2025-03-11 Soc Des Produits Nestle S A Star Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños.
EP3331534B1 (en) 2015-08-04 2019-12-18 Société des Produits Nestlé S.A. Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
CN108541221B (zh) 2015-12-15 2023-02-28 格礼卡姆股份公司 Hmo的混合物
EP3407740A1 (en) * 2016-01-26 2018-12-05 Nestec S.A. COMPOSITIONS COMPRISING 2FL AND LNnT TO CONTROL FOOD INTAKE AND GROWTH IN INFANTS OR YOUNG CHILDREN
CA3017371A1 (en) * 2016-03-11 2017-09-14 Evolve Biosystems, Inc. Food compositions for weaning
MX2018015187A (es) * 2016-08-04 2019-04-24 Nestec Sa Composiciones nutricionales con 2fl y lnnt para su uso en la prevencion y/o tratamiento de la diarrea no causada por rotavirus mediante la accion en la disbiosis de la microbiota intestinal.
AU2017307952A1 (en) * 2016-08-04 2018-11-29 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas comprising a mix of oligosaccharides and optionally Bifidobacterium lactis for preventing, treating or reducing the severity of non-rotavirus-associated diarrhoea
WO2018046311A1 (en) * 2016-09-07 2018-03-15 Nestec S.A. Nutritional compositions for infants and/or young children comprising oligosaccharides
CA3036553A1 (en) 2016-09-13 2018-03-22 Prothera Biologics, Inc. Methods for treating pulmonary disease using inter-alpha inhibitor proteins
KR102587810B1 (ko) 2017-04-25 2023-10-11 프로테라 바이오로직스, 인크. 인터-알파 억제제 단백질을 정량화하는 방법
AU2018272764B2 (en) * 2017-05-24 2024-05-30 Societe Des Produits Nestle S.A. HMOs blends for use in infants or young children for health purposes
US12628859B2 (en) 2017-07-07 2026-05-19 Societe Des Produits Nestle S.A. Human milk fortifier
EP3648617A1 (en) * 2017-07-07 2020-05-13 Société des Produits Nestlé S.A. Human milk fortifier
US20200221749A1 (en) * 2017-07-07 2020-07-16 Societe Des Produits Nestle S.A. Human milk fortifier
BR112020011242A2 (pt) * 2017-12-08 2020-11-17 Jennewein Biotechnologie Gmbh mistura seca por pulverização de oligossacarídeos de leite humano
DK3524067T3 (da) 2018-02-08 2025-05-19 Chr Hansen Hmo Gmbh Spraytørret blanding af modermælksoligosaccharider
CN110839702A (zh) * 2018-08-21 2020-02-28 内蒙古伊利实业集团股份有限公司 一种改善婴幼儿肠道菌群丰度和粪便气味的母乳低聚糖组合物及其应用
WO2020086879A1 (en) * 2018-10-24 2020-04-30 Prothera Biologics, Inc. Inter-alpha inhibitor proteins and methods of use thereof
AU2019395755B2 (en) * 2018-12-14 2025-05-29 Société des Produits Nestlé S.A. Stable aqueous composition comprising oligosaccharides
CN113163833A (zh) * 2018-12-21 2021-07-23 雀巢产品有限公司 包含6′sl和lnt的组合以改善胃肠屏障功能的营养组合物
ES3028208T3 (en) 2018-12-21 2025-06-18 Nestle Sa A nutritional composition comprising a combination of human milk oligosaccharides to improve the gastrointestinal barrier
CN109528777A (zh) * 2018-12-25 2019-03-29 东北农业大学 由鼠李糖乳杆菌和2`-岩藻糖基乳糖组成的组合物的应用
CN112075637B (zh) * 2020-04-27 2023-05-23 合生元（广州）健康产品有限公司 一种减少肠道气体产生的组合物
CN112841317B (zh) * 2021-02-04 2022-02-01 合生元（广州）健康产品有限公司 一种适用于高龄产妇喂养的婴幼儿的营养组合物
WO2024064327A1 (en) * 2022-09-22 2024-03-28 Abbott Laboratories Human milk oligosaccharides for enhancing blood-brain barrier function

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
CA2786710C (en) * 2010-01-19 2018-10-09 Abbott Laboratories Nutritional formulas containing synbiotics
EP2455387A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
NZ611807A (en) * 2010-12-31 2015-02-27 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
MX390997B (es) * 2011-10-18 2025-03-21 Soc Des Produits Nestle S A Star Composicion para su uso en la promocion de la angiogenesis intestinal y de la absorcion de nutrientes y de tolerancia a la alimentacion enteral y/o en la prevencion y/o en el tratamiento de la inflamacion intestinal y/o en la recuperacion posterior a un daño o cirugia intestinal.

Also Published As

Publication number Publication date
EP3071208B1 (en) 2021-08-11
PH12016500762A1 (en) 2016-05-30
US11135232B2 (en) 2021-10-05
RU2016123460A (ru) 2017-12-20
CN105744938A (zh) 2016-07-06
WO2015071402A1 (en) 2015-05-21
CN114522175A (zh) 2022-05-24
US20160296540A1 (en) 2016-10-13
AU2014350157A1 (en) 2016-04-14
ZA201604034B (en) 2019-04-24
EP3071208A1 (en) 2016-09-28
PT3071208T (pt) 2021-10-26
ES2895380T3 (es) 2022-02-21

Similar Documents

Publication Publication Date Title
PH12016500762A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
PH12016500773A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section
PH12016500868A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
PH12017550040A1 (en) Compositions for use in the prevention or treatment of gastrointestinal infections/inflammations in infants or young children
PH12017550044B1 (en) Compositions for use in the prevention or treatment of otitis or bronchitis in infants or young children
PH12018501325A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion
PH12016500764A1 (en) Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
PH12017502350A1 (en) Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
PH12018501262A1 (en) Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat allergies
PH12017550041B1 (en) Compositions for use in improving stool consistency or frequency in infants or young children
MX366368B (es) Metodos para el cuidado oral prebiotico usando un sacarido.
MX2015006358A (es) Composiciones nutricionales a base de leche que contienen lactoferrina y usos de las mismas.
TN2016000229A1 (en) Gabapentinoids and sigma receptor ligands combinations.
PH12020552241A1 (en) Use of polar lipids to treat or prevent gestational diabetes mellitus
PH12015502543B1 (en) Anti-regurgitation composition maintaining gut motility
NZ754706A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
PH12019500092A1 (en) Nutritional compositions for infants and/or young children comprising oligosaccharides
EP4470625A3 (en) A pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting
PH12017500466A1 (en) Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children
MX2017011838A (es) Composiciones y metodos para tratar carcinoma hepatocelular.
PH12014502030A1 (en) Lactoferrin for preventing or treating diarrhea
TH158883A (th) องค์ประกอบสำหรับใช้ในการป้องกันหรือการรักษาโรคลำไส้อักเสบชนิดเนื้อตาย ในทารกและเด็กเล็ก
KR20130112838A (ko) 은행-뽕잎 혼합 조성물 (제조법 잎갯수와 g수로 명시)
MX357132B (es) Uso de la inulina para el tratamiento de manifestaciones clínicas asociadas con la cirrosis hepática.
TH154744A (th) องค์ประกอบสำหรับใช้ในการป้องกัน และ/หรือ การรักษาของภาวะทางผิวหนังหรือโรคผิวหนัง